Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/
You can print this page and show it to your doctor.

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

ProPublica's Dollars for Docs database lets you search for payments to U.S.-based doctors made by pharmaceutical and medical device companies between August 2013 and December 2018. The disclosure of these payments is required under the Physician Payments Sunshine Act, a provision of the 2010 Affordable Care Act.

About This Information

  • The information that appears here comes directly from the federal government. Companies must attest to its accuracy, and doctors have the ability to contest information they believe is in error.
  • This site includes payments for such activities as speaking, consulting, meals, travel and royalties. It does not include payments for clinical research.
  • It is legal for companies to make payments to doctors as long as the payments are not a kickback or inducement to use their products.
  • Some doctors say collaborative relationships, particularly those involving research, are necessary to develop new treatments and cures. But many ethicists have raised questions about the payments, and studies show that they may influence doctors' prescribing decisions.
  • Only you can decide if this matters to you and if so, whether you want to talk with your doctor about it. If you plan to talk with your doctor (or if you already have), please help us by filling out this short survey: propub.li/participate-d4d

Preparing for Your Conversation

If you decide you'd like to talk to your doctor about this, please keep in mind:

  • Many health care professionals in our database have similar names, so you should start by asking your doctor if the person mentioned in this payment record is really him/her.
  • Your doctor may not know he or she is listed as receiving payments, especially if the payments are small. You can direct your doctor to this site (the URL will be printed at the top of the payment record) or directly to the government's site here: https://openpaymentsdata.cms.gov/physician/111745
  • Some doctors are happy to discuss this information with you. Others might not be. The best approach is to ask questions and to not be accusatory.

Questions You Might Want to Ask

  • Is this you?
  • What type of work do you do with these companies?
  • Have you prescribed me any drugs that are manufactured by companies you've taken payments from?
  • Are there non-drug alternatives that I may want to consider first?
  • Are there less expensive generic alternatives to the drugs you have prescribed?
  • What devices have you used in my care that are manufactured by companies you've taken payments from?

Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/doctors/pid/111745
If you spot an error, please let us know at [email protected].

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

KAMYAR KALANTAR-ZADEH

Listed Specialty: Nephrology
21840 NORMANDIE AVE, STE. 700, TORRANCE, CA, 90502-2047

2018 Payments: At a Glance

69

payments

$55,719

payment total

13

companies paid this doctor

Types of Payments

Category Payments Payment Value
Promotional Speaking/Other
 10 $21,425
Consulting
 7 $16,973
Travel and Lodging
 21 $11,245
Honoraria
 2 $4,075
Food and Beverage
 28 $1,532
Nonaccredited Training
 1 $469

Drugs & Devices in 2018

Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.

Product Name Product Type Payments†
AURYXIA

drug

 $15,695
VELPHORO

drug

 $10,382
NON-COVERED PRODUCT

drug

 $8,957
Payments with no listed product

N/A

 $6,582
NOT PRODUCT RELATED

device

 $3,820
TOLVAPTAN

drug

 $3,020
PARSABIV

drug

 $2,600
GIAPREZA

drug

 $1,773
VELOPHORO

drug

 $1,113
JYNARQUE

drug

 $784
FERAHEME

drug

 $500
RENAL - THERANOVA

device

 $469
INJECTAFER

drug

 $25
† May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products.

Payment Details

When How Much Related To What For From Third Party Payee
Dec 17, 2018 $6,525 AURYXIA Promotional Speaking/Other KERYX BIOPHARMACEUTICALS, INC.
Oct 20, 2018 $4,728 NON-COVERED PRODUCT Travel and Lodging CHUGAI PHARMACEUTICAL CO., LTD.
Oct 20, 2018 $3,675 NON-COVERED PRODUCT Consulting CHUGAI PHARMACEUTICAL CO., LTD.
Jul 30, 2018 $3,150 AURYXIA Consulting KERYX BIOPHARMACEUTICALS, INC.
Feb 16, 2018 $3,093 No Listed Product Consulting FRESENIUS KABI USA, LLC
May 14, 2018 $3,020 TOLVAPTAN Consulting OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
Apr 26, 2018 $3,000 VELPHORO Promotional Speaking/Other FRESENIUS USA MARKETING, INC.
Jul 28, 2018 $3,000 VELPHORO Promotional Speaking/Other FRESENIUS USA MARKETING, INC.
Jun 14, 2018 $2,875 NOT PRODUCT RELATED Honoraria FRESENIUS USA MARKETING, INC.
Jan 19, 2018 $2,200 PARSABIV Promotional Speaking/Other AMGEN INC.
Oct 26, 2018 $2,000 VELPHORO Promotional Speaking/Other FRESENIUS USA MARKETING, INC.
Sep 3, 2018 $1,735 No Listed Product Consulting VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD.
Oct 9, 2018 $1,700 AURYXIA Promotional Speaking/Other KERYX BIOPHARMACEUTICALS, INC.
Nov 29, 2018 $1,350 AURYXIA Promotional Speaking/Other KERYX BIOPHARMACEUTICALS, INC.
Jan 16, 2018 $1,250 No Listed Product Consulting ASTRAZENECA PHARMACEUTICALS LP
Jul 17, 2018 $1,200 GIAPREZA Honoraria LA JOLLA PHARMACEUTICAL COMPANY
Dec 17, 2018 $1,050 VELOPHORO Consulting VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD.
Aug 7, 2018 $750 JYNARQUE Promotional Speaking/Other OTSUKA AMERICA PHARMACEUTICAL, INC. Kalantar Dot Com Inc
Apr 26, 2018 $596 VELPHORO Travel and Lodging FRESENIUS USA MARKETING, INC.
Oct 9, 2018 $567 AURYXIA Travel and Lodging KERYX BIOPHARMACEUTICALS, INC.

For ease of printing, 20 payments are displayed, the largest appearing on top. For a full list of payments, please visit: https://projects.propublica.org/docdollars/doctors/pid/111745

Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].

This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.